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Adult C57BL/6 (B6) orC57BL/10 mice inoculated with LP-BM5 murine leukemia
viruses (MuLV)l develop a syndrome characterized by progressive lymphadenop-
athy, splenomegaly, and increasingly profound immunodeficiency with death oc-
curring at 16-26 wk after infection (1-3). The advanced stages of this syndrome,
termed murine acquired immunodeficiency syndrome (MAIDS), areassociatedwith
enhanced susceptibility to infection (4) and the development of B cell lineage lym-
phomas (5, 6).
The present studies were based on the observations that congenitally-athymic
C57BL/10-nu/nu mice are resistanttothe immunodeficiency diseaseinduced by LP-
BM5 MuLV, but that susceptibility is reconstituted in these animals by injection
ofpurified, mature T lymphocytes (7). These findings clearly demonstrate that de-
velopment ofB cell dysfunction in MAIDS is dependent on the presence of func-
tional T cells. Almost all peripheral T cells in the mouse belong to one of two sub-
populationsthat aremutually exclusivein theirexpression ofthe cell surfaceantigens
CD8 and CD4 (8). A number of functional attributes also serve to distinguish be-
tween CD8',CD4- , and CD8-,CD4+ T cells, henceforth referred to as CD8+ and
CD4' cells, respectively. CD8+ T cells usually respond to antigens associated with
class I molecules ofthe MHC, whereas CD4' cells generally recognize antigens in
association with class II MHC determinants. In addition, activated CD8' T cells
can exhibit CTL or suppressor activities, whereas CD4' T cells usually help or in-
duce otherTcells orB cells toproliferate, differentiate, orperform avarietyofeffector
functions (8).
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The observations ofpolyclonal B cell activation and differentiation during the course
of MAIDS, together with the understanding that normal B cell activation is usually
dependent on lymphokines produced by CD4+ rather than CD8' T cells (9-12),
suggested to us that hyperactivity of CD4` cells might contribute to the pathogen-
esis of this syndrome, and that elimination of these cells could inhibit the develop-
ment of disease. The opportunity to evaluate this possibility was provided by the
demonstration that CD4+ cells can be depleted in vivo by treatment with the anti-
CD4-specific mAb GK1.5 (13, 14). We report here that depletion of CD4+ T cells
in mice before infection with LP-BM5 MuLV inhibited the development of many
of the immunologic abnormalities characteristic of MAIDS, and that established
disease was reversed by modifications of this depletion regimen.
Materials and Methods
Mice and Viruses.
￿
C57BL/6J (B6) mice were purchased from TheJackson Laboratory(Bar
Harbor, ME) and were inoculated with 0.1 ml LP-BM5 MuLV at 4 wk of age. LP-BM5 MuLV
consist of a mixture ofB-tropic ecotropic (eco) and B-tropic mink cell focus-inducing (MCF)
MuLV (1-6, 15). Adult B6 mice inoculated with this virus mixture (LP-BM5 eco+MCF)
exhibit replication ofboth virus classes in spleen and lymph node, develop lymphadenopathy,
splenomegaly, and immune defects within 4 wk of infection, and die between 12 and 26 wk
after injection (1-6). Biologically cloned isolates of LP-BM5 eco, obtained by limiting dilu-
tion titrations in tissue culture, replicate efficiently in lymphoid tissues of B6 mice infected
as adults, but the animals do not develop prominent lymphoproliferation or immunodeficiency
and live for at least 1 yr (Lee, J. S., R. A. Netter, K. L. Elkins, K. L. Holmes, J . W. Hartley,
H. C. Morse, III, manuscript in preparation). Uncloned stocks of LP-BM5 MCF MuLV,
free of ecotropic virus, replicate poorly in tissues of mice infected as adults, and inoculated
mice live for more than 6 mo without signs ofdisease (our unpublished observations). Devel-
opment of disease thus appears to be related to unique features of the LP-BM5 MCF virus
that are dependent on LP-BM5 eco for efficient spread in vivo, or to undefined interactions
of the eco and MCF components of the virus mixture.
Virus stocks of LP-BM5 eco and LP-BM5 eco+MCF were prepared from chronically in-
fected SC-1 cells. Titers of ecotropic MuLV were determined by the XC plaque test (16),
and mink-infectious (MCF) viruses were titered using a fluorescent antibody focus-forming
assay (17). The LP-BM5 eco pool contained 10'_5 plaque forming units (PFU)/0.2 ml. The
LP-BM5 eco+MCF pool contained 10" PFU/0.2 ml ecotropic virus and 1033 focus-forming
units (FFU)/0 .2 ml of MCF virus.
Infectious center assays in tissue culture were performed by cocultivation of mitomycin
C-treated spleen cells with SC-1 cells for assays of ecotropic MuLV by the XC plaque test
and with mink lung cells for assays ofMCF viruses by the fluorescent antibody focus-forming
tests (16, 17). Titers of ecotropic MuLV are expressed as logo PFU/107 cells and titers of
mink-infectious virus as logio FFU/10' cells.
Treatment ofMice withAnti-CD4 Antibody.
￿
Anti-CD4 mAb GK1.5 was grown in ascites and
prepared for inoculation of mice as described (14). Inoculation protocols are detailed in the text.
Flow Microfluorometry (FMF).
￿
Single cell suspensions ofperipheral lymph nodes were pre-
pared and stained for FMF assays as described (18, 19). Theorigins, characteristics, and nominal
specificities of mAbs to Thy-1.2, la, CD8, CD4, Mac-1, and xenoantibodies to x light chain
used in this study were detailed previously (18, 19). All antibodies used were directly con-
jugated with FITC. FMF assays were performed on 3 x 103 viable cells, determined by light
scatter and exclusion of propidium iodide, using a flow cytometer (FAGS 440; Becton Dick-
inson & Co., Mountain View, CA) equipped with an argon and an argon/dye laser (18, 19).
Serum IgM Assays.
￿
Levels of IgM in sera were determined by an ELISA assay, to be de-
scribed elsewhere (Lee, J. S., et al., manuscript in preparation) using TEPC 183 IgM as a
standard .
Immunization.
￿
Mice were inoculated with an optimally immunogenic dose (10 gg i.p.) ofYETTER ET AL.
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TNP-Ficoll (20). 4 d later, TNP-specific plaque forming cell (PFC) responses of spleen cells
were determined by established techniques using TNP-coupled SRBC (20).
Generation of CTL. Cytotoxic effector cells were generated in 24-well trays by coculturing
4 x 106 irradiated (2,000 rad) BALB/c (H-2'd) stimulator spleen cells with 3 x 106 B6 (H-26)
responder spleen cells in a final volume of 2 ml for 5 d (21). The activity of effector cells
was tested in a 4-h "Cr-release assay with Con A-stimulated BALB/c spleen cells as targets.
The relative CTL activity generated in individual mixed lymphocyte cultures was compared
using a standardized measure of cytotoxic units (CU) per culture (21).
Histopathology.
￿
Portions of spleen and lymph node obtained at autopsy were sectioned,
stained with hematoxylin and eosin, and examined microscopically.
Results and Discussion
Depletion of CD4+ T Cells from Virus-infected Mice Inhibits Lymphoproliferation and
Phenotypic Changes in Lymph Node Cell Subpopulations. Adult B6 mice were depleted
of CD4 + T cells by intraperitoneal inoculations with 1 mg of mAb GK1.5 at days
-4 and -1 before infection with LP-BM5 eco+MCF and every 3-5 d thereafter for
the duration of the experiments. Mice treated with the mAb were compared with
untreated mice infected with the virus mixture, and with untreated mice injected
with the relatively nonpathogenic LP-BM5 eco virus alone. Untreated animals in-
fected with LP-BM5 eco+MCF exhibited splenomegaly (Table I) and lymphade-
nopathy (by gross observation) at 4 wk after infection that was progressive through
12 wk. In contrast, spleen weights of mice infected with LP-BM5 eco+MCF but
treated with mAb GK1 .5 before infection were similar to those of mice infected with
LP-BM5 eco or uninfected controls at each time point (Table I). Lymph nodes of
mice infected with LP-BM5 eco+MCF and treated with mAb GK1.5 were also noted
to be of similar size to mice infected with LP-BM5 eco.
To evaluate the effects of infection with LP-BM5 eco+MCF and treatment with
mAb GK1.5 on lymph node cells, single cell suspensions prepared from peripheral
nodes were examined by FMF for the proportions of cells expressing Thy-1, CD8,
CD4 (Fig. 1), x Ig light chain, Ia, and Mac-1 (Fig. 2) cell surface antigens. In con-
trast to normal mice or mice infected with LP-BM5 eco, mice infected with LP-BM5
eco+MCF demonstrated a significant depletion of Thy-1 + cells in lymph node (Fig.
1 a) due to losses of both CD8 + (Fig. 1 c) and CD4+ T cells (Fig. 1 e). The propor-
TABLE I
Depletion of CD4+ T Cells Prevents Splenomegaly in Mice Infected with
LP-BM5 eco+MCF
Mice infected with LP-BM5 eco, LP-BM5 eco+MCF, or LP-BM5 eco+MCF after depletion
ofCD4' cells (LP-BM5 eco+MCF/CD4- ), were killed, and spleen weights were determined.
Numbers indicate mean spleen weight ( t 1 SE) for three to six mice in each group. Results
at the 4- and 8-wk time points are representative ofthree and two experiments, respectively.
Data at 12 wk after infection are from a single experiment. Mean spleen weight for eight
uninfected controls is 80 t 10 mg.
Weeks after
infection LP-BM5 eco LP-BM5
Spleen weight'
eco+MCF
mg
LP-BM5 eco+MCF/CD4-
4 90 1 3 210 1 16 110 1 10
8 100 t 10 380 t 40 90 f 10
12 107 t 10 450 t 90 93 ± 12626
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FIGURE 1 .
￿
FMF analyses ofT cell populations in peripheral lymph nodes . Single cell suspen-
sions from pooled peripheral lymph nodes were stained with FITC-labeled mAbs to Thy-1 (a,
b), CD8 (c, d), and CD4 (e, _~ and analyzed on a FAGS . The shaded areas represent the mean
(± 1 SE) percent antigen-positive cells in nodes of 10-21 uninfected normal mice (a, c, e) or 7
uninfected mice treated withmAbGK1.5 for4wk (b, d, f) . Points indicate mean (± SE) percent
positive cells for mice infected with LP-BM5 eco (-EI-) LP-BM5 eco+MCF (-A-), or infected
with LP-BM5 eco-MCF after treatment with mAb GK1.5 (-*-), and assayed at the indicated
times after infection (three mice/point) . Mice treated with mAbs werejudged to be numerically
and functionally depleted of CD4' cells by the following criteria . First, <1% oflymph node cells
from mice injected with themAbwere reactive with FITC-labeled anti-CD4 antibody (/). Second,
no more than 3% of cells from treated mice were reactive with FITC-labeled anti-rat Ig, indi-
cating that few CD4' cells coated with circulating mAb were present in these tissues . Third,
the frequencies ofCD8' cells in nodes (d) approximated, within 5%, the frequencies ofThy-1'
cells (b), indicating that few Thy-1' , CD8- , CD4- T cells were present in these tissues . Finally,
studies of similarly treated, uninfected mice demonstrated that they were unable to generate Th
cell-dependent antibody responses after immunization withSRBC or infection with ectromelia
virus (14) .YETTER ET AL.
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FIGURE 2.
￿
FMF analyses ofB cell andmacrophage populations in peripheral lymphnodes . The
same cell preparations described in the legend to Fig. 1 were stained with FITC-labeled goat
anti-mouse K antibodies (a, b) or FITC-labeled mAbs to la (c, d) or Mac-1 (e, f) . Shaded areas
and data points indicate means (± 1 SE) for normal andexperimental mice as indicated in the
legend to Fig. 1 .
tional loss ofCD4+ T cells in mice infected with LP-BM5 eco+MCF was equiva-
lent to that in mice infected with LP-BM5 eco, indicating that LP-BM5 MCFMuLV
were not responsible for this change . By comparison, decreases in CD8+ cells were
observed only after infection with the mixed virus preparation .
These alterations inT cell frequencies in mice infected with LP-BM5 eco+MCF
were associated with significant changes in the proportions of K+ B cells, Ia+ cells
(B cells and macrophages), and Mac-1 + macrophages in relation to their represen-
tations in lymph nodes ofnormal mice or mice infected with LP-BM5 eco (Fig. 2) .
The frequency of x+ cells increased almost twofold at 4 wk after infection and628
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gradually decreased thereafter (Fig. 2 a). The reduced frequency of x+ cells at the
8- and 12-wk time points may be related to the progressive expansion of B cell im-
munoblasts that, like plasma cells, express very lowlevels of surface Ig (see below),
and to clonal proliferations of B cells and pre-B cells that can firstbe detected around
12 wk after infection (5). The moderately increased frequencies of B cells in lymph
nodes of mice infected with LP-BM5 eco were similar to those observed after infec-
tion of B6 mice with other B-tropic or NB-tropic MuLV (Lee, J. S., et al., manu-
script in preparation), suggesting that both components of the virus mixture can
influence B cell proliferation. The frequencies of Ia+ cells (Fig. 2 c) and Mac-l'
cells (Fig. 2 e) in nodes of mice infected with LP-BM5 eco+MCFwere significantly
and persistently increased at 4-12 wk after infection. Many of the cells expressing
high levels of Ia (see below) were B cell blasts simultaneously expressing low levels
of membrane Ig, and most Mac-1+ cells were also Ia+ (data not shown). The fre-
quencies of cells expressing la and Mac-1 remained within normal ranges in mice
infected with LP-BM5 eco (Fig. 2, c and e).
Parallel studies of mice treated with mAb GK1.5 before infection with LP-BM5
eco+MCF showed that complete depletion of CD4+ T cells (Fig. It) prevented the
development of each of these alterations in lymphnode cell subpopulations. In com-
parison to normal mice depleted of CD4+ cells, depleted mice infected with the
virus mixture showed no significant changes in the frequencies of Thy-1+ or CD8+
T cells (Fig. 1, b and d) or x+, Ia+ , or Mac-1+ cells during the 12-wk observation
period (Fig. 2, b, d, andf). Depletion of CD4+ cells before infection thus prevented
the development of lymphoproliferation and changes in lymphoid populations that
are characteristic of MAIDS.
It should be noted that the effects of depleting CD4+ cells cannot be attributed
to elimination of macrophages. In both man and rats, macrophages as well as T
cells express cell surface antigens homologous to CD4 (22, 23). However, we (data
not shown) and others (24) have demonstrated that mouse macrophages are CD4- ,
indicating that thepreventive effects of treatmentwith mAb GK1.5 were due to deple-
tion of CD4+ T cells.
Inhibition of B Cell Abnormalities in Virus-infected Mice by Depletion of CD4+
Cells. Abnormalities of B cells in mice infected with LP-BM5 eco+MCF include
explosive follicular hyperplasia, enhanced differentiation to Ig-secreting cells, and
failure to generate antigen-specific responses on immunization with Th-dependent
or Th-independent antigens (1-3). In lymph nodes andspleens ofmice infected with
LP-BM5 eco+MCF, B cell hyperplasia was marked by an early expansion of lym-
phoid follicles, followed by distortions of normal follicular structure, and finally, by
nearly complete effacement of normal architecture (data not shown). By compar-
ison, lymph nodes and spleens of mice infected with LP-BM5 eco or LP-BM5
eco+MCF but depleted of CD4+ cells before infection exhibited none of these per-
turbations of lymphoid structure (data not shown).
Polyclonal B cell activation in mice infected with LP-BM5 eco+MCF was also
evidenced by the appearance ofB cell blasts that expressed reducedlevels of surface
Ig. At 8 wk after inoculation, the majority of x+ cells in lymph nodes of mice in-
fected with LP-BM5 eco+MCF (Fig. 3, c and d) stained with lower intensity and
were considerably larger, as judged by forward angle light scatter, than x+ cells in
lymph nodes of mice infected with LP-BM5 eco (Fig. 3, a and b). By comparison,E
a
E
0
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FIGURE 3 .
￿
FMFanalyses ofx' cells in lymph node from infected mice . Single cell suspensions
prepared from peripheral lymph nodes of mice infected 8 wk previously with LP-BM5 eco (a,
b), LP-BM5 eco+MCF (c, d), or infected mice depleted of CD4' cells (e, J) were reacted with
FITC-labeled goat anti-mouse 1c light chain antibodies and analyzed on a FACS. Single param-
eter fluorescence profiles (a, c, e) demonstrate increased frequencies of dull x' cells in lymph
nodes ofmice infected with LP-BM5eco+MCF (c). Two-parameter(fluorescence vs . light scatter)
contourmaps oflymph node cells (b, d, f) demonstrate the presence of dull
K+ cells of increased
size (d) present in lymph nodes of mice infected with LP-BM5 eco+MCF that are not seen in
cells from infected mice depleted of CD4+ cells .
the staining levels and sizes of x+ cells in lymph nodes of infected mice depleted
ofCD4+T cells (Fig. 3, e andf) were comparable to x' cells from uninfected mice
or from mice infected with ecotropic virus alone .
Lymphnode cells from thesame mice were also studied for levels of Ia expression .
Thelevels of class II antigens were greatlyincreased on B cells ofmice infected with
LP-BM5 eco+MCF In contrast, levels of Ia expression on B cells of infected mice
depleted of CD4+ T cells were similar to the levels on B cells from mice infected
with LP-BM5 eco (data not shown).
Hypergammaglobulinemia is another hallmark ofB cell dysfunction in MAIDS
(1-3). Studies of sera from infected mice showed that IgM levels of animals inocu-
2poo 1
1,000
-o- LP-BM5 eco
+ LP-BM5 eco + MCF
-~ LP-BM5 eco + MCF/Ly-4-
Weeks After Infection
YETTER ET AL .
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FIGURE 4 . IgM levels in sera from in-
fected mice . Sera collected from infected
mice were tested for IgM levels by an
ELISA assay (Lee,J . S., et al ., manuscript
in preparation) using purified TEPC 183
IgM as a standard .630
￿
T CELLS IN MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME
FIGURE 5 .
￿
AllogeneicCTL responses of
mice infected with LP-BM5MuLU. Mice
infected with LP-BM5 eco, LP-BM5 eco+
MCF, orLP-BM5eco+MCF afterdeple-
tion of CD4' cells (LP-BM5 eco+MCF/
CD4- ) were killed at 4, 8, and 12 wk after
infection for assays of splenic allogeneic
CTL reactivity. Bars indicate the means
(± 1 SE)ofcytotoxic units/culture (21) for
spleen cells from three to eight mice stimu-
lated for 5 d in vitro with irradiated (2,000
rad) BALB/c spleen cells and assayed on
5 ICr-labeled, Con A-stimulated BALB/c
spleen cell blasts .
lated withLP-BM5 eco+MCFwere increased more than fivefold at4 wk after infec-
tion and gradually decreased at 8-12 wk (Fig . 4) . By comparison, IgM levels in sera
of mice infected with LP-BM5 eco or LP-BM5 eco+MCF after depletion ofCD4+
cells remained at essentially normal levels at all times after infection .
The ability ofB cells to generate antigen-specific PFC responses to Th-dependent
antigens is absent in mice depleted ofCD4+ cells (13, 14), whereas responses to at
least some Th-independent antigens may be much less affected (data not shown) .
To evaluate the function of B cells in MAIDS, we immunized mice with the Th-
independent antigen, TNP-Ficoll (20) . At 8 wk after inoculation, the responses of
mice infected with LP-BM5 eco+MCF were negligible (11 PFC/106 spleen cells),
but a substantial response (63 PFC/10 6 cells) was generated by infected mice
depleted of CD4+ T cells .
We conclude that depletion ofCD4+ cells before infection with LP-BM5 MuLV
inhibits the development of most ifnot all of theB cell abnormalities associated with
MAIDS including lymphoproliferation, polyclonal B cell activation, hypergam-
maglobulinemia and impaired specific antibody responses to a Th-independent
antigen .
Inhibition ofAllogenicCTLDysfunction in Virus-infectedMice.
￿
We reported elsewhere
thatT cells of mice infected with LP-BM5 eco+MCF exhibited a variety of abnor-
malities, including markedly depressed in vitro CTL repsonses to TNP-modified
autologous cells (self + x) (3 ; Netter, R. A ., G. Shearer, M . Miller, H. C . Morse,
III, manuscript in preparation) and alloantigens (2) and in vivo CTL responses to
ectromelia virus (4) . Since CD4+ Th cells are not required for induction of allo-
genic CTL responses (25, 26), we studied the ability of spleen cells from infected
B6 (H-2b) mice to generate CTL after cocultivation with irradiated BALB/c (H-2d)
spleen cells (Fig. 5) . In agreement with other studies (2, 3), B6 mice infected with
LP-BM5 eco+MCF showed an early and progressive loss of allogenic CTL reac-
tivity in comparison to mice infected with LP-BM5 eco . In contrast, allogenic CTL
responses of infected mice depleted ofCD4+ cells did not differ significantly from
those of mice infected with LP-BM5 eco. These results indicate that depletion of
CD4+ cells before infection prevents development of one of the major T cell dys-
functions evidenced in mice infected with LP-BM5 eco+MCF .YETTER ET AL.
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TABLE II
Expression of Infectious MuLV in Spleen Cells of Normal and CD4+
T Cell-depleted Mice Infected with LP-BM5 eco +MCF
" Infectious center assays in tissue culture were performed by cocultivation of
mitomycin C-treated spleen cells with SC-1 cels for assays ofecotropic MULV
by the XC plaque test (16) and with mink lung cells for assays of mink-infectious
viruses by a fluorescent antibody focus-forming test (17). Titers of ecotropic
virus are expressed as logio PFU/107 cells and titers of mink infectious virus
as loglo FFU/107 cells. Numbers indicate the mean (± 1 SE) for assays of
spleen cells from three mice per group.
Expression ofInfectiousMuLVin Virus-infectedMice.
￿
To examine thepossibility that
differences in immune function between mice infected with LP-BM5 eco+MCF and
infected mice depleted of CD4+ cells could be explained by alterations in virus ex-
pression, spleen cells from inoculated mice were tested for production of ecotropic
and MCF MuLV. As shown in Table II, there were no significant differences be-
tween the proportions of spleen cells producing ecotropic or MCF viruses in either
set of mice at 4 or 8 wk after infection. These results suggest that CD4+ T cells
are not the primary targets for infection by LP-BM5 viruses, and are not required
for infection of other cell types.
Treatment ofMAIDS with mAb GK1.5.
￿
The results presented above indicated that
depletion of CD4+ cells before infection with LP-BM5 eco+MCF prevented the
development of most of the major manifestations of MAIDS. To determine if CD4+
cells were required not only to initiate but also to sustain the immunologic abnor-
malities characteristic ofthe syndrome, mice were infected with LP-BM5 eco+MCF,
and the disease was allowed to develop for 2 wk before treatment with mAb GK1.5
was initiated using the protocol diagrammed in Fig. 6 a. After 4 wk of treatment,
16 of 17 mice in two experiments had <1% CD4+ cells in lymph nodes and <4%
anti-rat Ig+ cells (data not shown) .
Additional FMFstudiesoflymph node cells from depleted mice showed that they
closely resembled cells from mice depleted of CD4+ cells before infection; they in-
cluded few dull x+ blast cells, and the intensity of Ia staining on B cells was equiva-
lent to that detected on cells from uninfected mice. In addition, the frequencies of
Thy-1+, x+, Ia+ , and CD8+ cells were similar to those of mice treated with anti-
body before infection (data not shown).
Further studies of mice completely depleted of CD4+ T cells after infection
showed that they exhibitedminimallymphadenopathy andhad spleen weightssimilar
to those of uninfected mice or mice infected with LP-BM5 eco (Fig. 6 b). Serum
IgM levels were in the range for uninfected mice and were considerably lower than
untreated mice infected with LP-BM5 eco+MCF(Fig. 6 c). In this experiment, spleen
cells from mice were assayed for generation ofallogeneic CTL in vitroand for TNP-
Weeks after
infection Treatment
Virus
Ecotropic MuLV
(logio PFU/107 cells)
expression'
MCF MuLV
(logio FFU/107 cells)
4 None 4.3 1 0.1 1 .0 ± 0.2
GK1 .5 4.8 ± 0.1 0.9 ± 0.2
8 None 4.5±0.1 1 .9±0.1
GK1 .5 4.7 ± 0.1 1 .5 ± 0.2632
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FIGURE 6 .
￿
Treatment of LP-BM5 MuLUinduced disease by depletion of CD4' T cells . The
experimental protocol is outlined in (a) . At 6 wk post infection, 9 mice in each experimental
group were sacrificed and examined for spleen weight (b), serum IgM levels (c) and CTL re-
sponses to allogeneic (BALB/c, H-2d) stimulator cells . Bars indicate themean (t 1 SE) for mice
in each group.
specific PFC 4 d after immunization with TNP-F. As expected, the CTL responses
ofmice infected with LP-BM5 eco+MCF were greatly impaired, whereas normal
responses were generated by infected mice depleted ofCD4+ T cells (Fig . 6 d) . In
parallel with earlier studies, mice infected with LP-BM5 eco+MCF were markedly
deficient in the generation of antigen-specific PFC after immunization with TNP-
Ficoll ; however, a low but significant PFC response was detected in spleen cells of
infected mice depleted of CD4+ T cells (data not shown) . Histologic studies of
spleens and lymph nodes from antibody-treated mice showed a return of distorted
follicular areas towards normal (data not shown) . Finally, spleen cells from mice
infected with LP-BM5 eco+MCF or from infected mice depleted of CD4' cells
wereexamined in infectious center assays for expression of infectious ecotropic andYETTER ET AL.
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MCF viruses. Equivalent frequenciesofvirus-producing cellswere detected among
spleen cells from mice of both groups (data not shown).
The results ofour studies demonstrate that depletion ofCD4' T cells was effec-
tive in preventing many ofthe immunologic abnormalities that develop within the
first 12 wkafterinfection with LP-BM5 eco+MCF, and that established diseasecould
be reversed byeliminationofthis Tcell subset. These findings indicatethat dysfunc-
tion of CD4' Tcells is central to the induction and progression of both B and T
cell abnormalities in MAIDS. The mechanisms by which infection with LP-BM5
MuLVactivates and alters the functionsofthese cells is not known, although previous
studies (6) suggest that infection ofT cells by these viruses occurs at low frequencies
ifat all. In situ hybridization studies demonstrating virus in marginal zone macro-
phages at one week after infection (Mosier, D. E., R. Gulizia, D. Spector, unpub-
lished observations) suggest that CD4' T cell/macrophage interactions may con-
tribute to the activation process.
Although the present studies clearly indicate the pivotal role of activated CD4'
T cells in MAIDS, the exact means by which these cells influence the functions of
B cells and other T cells remains to be determined. Recent studies demonstrating
greatly impaired IL-2 production (Yetter, R. A., et al., manuscript in preparation)
in association with markedly stimulated gammainterferon production (Pitha, P M.,
D. Biegel, R. A. Yetter, and H. C. Morse, III, submitted for publication) in mice
infected with LP-BM5 MuLV suggest that imbalances among immunoregulatory
products ofCD4' cells may be ofimportance. Our studies do not exclude the pos-
sibility that CD8+ cells may also contribute to the pathogenesis of MAIDS in un-
treated mice, but they strongly suggest that, in the absence of CD4' cells, CD8
cells have little if any effect on disease progression.
The effect ofdepleting CD4' cells on the late sequelae ofvirus infection (short-
ened life span, enhanced susceptibility toinfection, and development oflymphomas)
is not known. We have found that mice incompletely depleted ofCD4' T cells be-
fore orafterinfectionexhibit abnormalities that presage the appearance ofoligoclonal
populations ofB cells and failure to generate virus-specific CTL responses (data not
shown) indicating the induction or progression of MAIDS is inhibited only to the
extent that CD4' T cells are depleted. Indeed, cessation of treatment with mAb
was associated with development of fulminant disease.
The implications of our results for understanding the pathogenesis ofthe HIV
induced immunodeficiency syndrome ofman are asyet unknown, although numeric
and functional abnormalities ofCD4` are prominent features ofAIDS (27) as well
as MAIDS. It seeems likely, however, thatthedevelopment ofdetailedunderstandings
of retroviral pathogenesis in immunodeficiency syndromes ofthe mouse, cat, and
nonhuman primates will contribute to a dissection ofthe mechanisms operative in
the human disease.
Summary
Mice depleted in vivo of CD4' Th cells by treatment with mAb GK1.5 were
found to beresistantto thelymphoproliferative/immunodeficiency disease (MAIDS)
induced in intact mice by infection with the mixture ofLP-BM5 murine leukemia
viruses. Depleted mice did not developlymphadenopathyorsplenomegaly, had normal
serum IgM levels, normal CTLresponses to alloantigens, and were able to generate634
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PFC responses to Th-independent antigens even though frequencies ofvirus-producing
spleen cells were comparable in depleted and intact mice. Depletion of CD4+ Th
cells after infection resulted in a reversal of many abnormalities exhibited by in-
fected controls; spleen weights, serum IgM levels, and allogeneic CTL responses
of treated mice were comparable to those of uninfected controls. These results dem-
onstrate that dysfunction of CD4+ Th cells is central to the induction and progres-
sion of both T and B cell abnormalities in MAIDS.
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